A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
Trial details
- Registry ID
- NCT02029430
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's SarcomaNCT02029430 | IBRX | Phase 2 | Completed | 2016-04-25Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |